AN
Insider
Amir Nashat
DirectorAmir Nashat (Director) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). Across 2 priced purchase filings, the average 21-session return was +32.7% from execution and +32.7% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of CAMP (909,090 sh × $11.00, as filed), executed Oct 15 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+32.7%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+32.7%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.0M
shares × price, as filed
Last traded
Sep 11 2025
Filed Sep 11 2025
Median ADV $1.1M across their filed names
Open performance→Volume by month
Buys $12.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
CAMPRecent filings
CAMPPURCHASE
CAMP4 THERAPEUTICS CORPORATION
View filing →
$2.0M1,307,189 sh across 2 lots
Exec Sep 11 2025
Filed Sep 11 2025 · 4:48 PM ET CAMPPURCHASE CAMP4 THERAPEUTICS CORPORATION View filing → $10.0M
909,090 sh × $11.00
Exec Oct 15 2024
Filed Oct 15 2024 · 5:30 PM ET